Track record · closed signal

Xp Inc (XP) — closed signal from April 6, 2026

Target reached Published before the outcome was known, scored automatically when the window closed on July 5, 2026 — -13.3% at the close.

Predicted vs. what happened

XP price · publication thesis → realized outcomesplit-adjusted
$18.65 Published $20.80 Target $16.16 Window close $21.51 Peak
$17.74 – $18.61Entry zone — fair-value band
$18.65Published — price the day we called it
$20.80Target — the price the thesis aimed for
$21.51Peak — highest point inside the window, not a realized return
$16.16Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 9 days.

At window close
-13.3%
realized, from the publication price to the last close inside the window
Peak gain
+15.3%
peak, from the publication price — not a realized return
S&P 500, same window
+13.3%
SPY over the identical days, dividend-adjusted
Window close
$16.16
last close inside the window, ended July 5, 2026
Peak price
$21.51
peak on April 17, 2026 — not a realized return
Days to target
9

The thesis — published April 6, 2026

Predicted growth
+13%
over the measurement window
Target price
$20.80
the price the thesis aimed for
Entry zone
$17.74 – $18.61
the fair-value band we waited for
Price at publication
$18.65
published April 6, 2026
Confidence
72%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

XP looks like an early recovery: the stock is reasonably priced, profits are healthy, and analysts raised targets because more people are trading in Brazil. The price is holding near its trend, which helps manage downside. This is a constructive setup but still early; country-specific news can quickly change momentum, so confidence is moderate.

Primary drivers

  • Reasonable price gives room for a valuation lift if activity holds
  • More retail trading lifts near-term revenue potential
  • Higher analyst targets act as a visible catalyst
  • Price sitting in a base supports a measured recovery plan

How it played out

XP: target reached in 9 days

Lyra published XP as an early recovery with 13% expected growth. The thesis pointed to a reasonable valuation, healthy profits, more retail trading, higher analyst targets, and a price base that supported a measured recovery. Confidence was moderate because country-specific news could change momentum.

The shares reached the $20.80 target in 9 days and peaked at $21.51 on April 17, a 15.3% gain from the published price of $18.65. They later fell and ended the window at $16.16. The thesis played out within the measurement window, but the gain did not hold through the end.

What happened during the window

On May 18, 2026, XP reported first-quarter gross revenue of R$4.92 billion, up 8% from a year earlier. Adjusted net income was R$1.32 billion, up 7%.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All XP signals